1. Home
  2. MREO vs ZEPP Comparison

MREO vs ZEPP Comparison

Compare MREO & ZEPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mereo BioPharma Group plc

MREO

Mereo BioPharma Group plc

SELL

Current Price

$0.30

Market Cap

50.3M

Sector

Health Care

ML Signal

SELL

Logo Zepp Health Corporation

ZEPP

Zepp Health Corporation

N/A

Current Price

$2.66

Market Cap

56.6M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
MREO
ZEPP
Founded
2015
2013
Country
United Kingdom
Netherlands
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Manufacturing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
50.3M
56.6M
IPO Year
2017
2017

Fundamental Metrics

Financial Performance
Metric
MREO
ZEPP
Price
$0.30
$2.66
Analyst Decision
Buy
Analyst Count
8
0
Target Price
★ $1.96
N/A
AVG Volume (30 Days)
★ 632.5K
75.6K
Earning Date
11-09-2026
11-22-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 16.67
N/A
EPS
N/A
★ N/A
Revenue
★ $500,000.00
N/A
Revenue This Year
$59.51
$14.24
Revenue Next Year
$2,326.81
$6.50
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.20
$2.15
52 Week High
$2.37
$32.85

Technical Indicators

Market Signals
Indicator
MREO
ZEPP
Relative Strength Index (RSI) 50.90 43.53
Support Level $0.27 $2.19
Resistance Level $0.35 $5.57
Average True Range (ATR) 0.02 0.25
MACD 0.00 0.11
Stochastic Oscillator 62.55 42.70

Price Performance

Historical Comparison
MREO
ZEPP

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About ZEPP Zepp Health Corporation

Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands. Geographically, the group generates revenue from Asia-Pacific, Europe, North America and others.

Share on Social Networks: